Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors

BACKGROUND: The National Comprehensive Cancer Network recommends either three cycles of bleomycin, etoposide, and cisplatin or four cycles of etoposide and cisplatin (EPx4) as initial chemotherapy for the treatment of good‐risk germ cell tumors (GCTs). To assess the response, toxicity, and survival...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Funt, Samuel A., McHugh, Deaglan J., Tsai, Stephanie, Knezevic, Andrea, O'Donnell, Devon, Patil, Sujata, Silber, Deborah, Bromberg, Maria, Carousso, Maryann, Reuter, Victor E., Carver, Brett S., Sheinfeld, Joel, Motzer, Robert J., Bajorin, Dean F., Bosl, George J., Feldman, Darren R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2021
Soggetti:
Genitourinary Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176973/
https://ncbi.nlm.nih.gov/pubmed/33586274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13719
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi